Online:
Visits:
Stories:
Profile image
By marketresearchnest
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Behcet Disease Therapeutics Market Pipeline Review H1 2017

Thursday, May 18, 2017 4:28
% of readers think this story is Fact. Add your two cents.

(Before It's News)

MarketResearchNest.com adds “Behcet Disease – Pipeline Review, H1 2017” new report to its research database. The report spread across in multiple pages with table and figures in it.

 

Latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease – Pipeline Review, H1 2017, provides an overview of the Behcet Disease (Cardiovascular) pipeline landscape.

Behcet disease (BEH-chets), sometimes called Behcet syndrome, Morbus Behcet, or Silk Road disease, is a rare immune-mediated systemic vasculitis. The more common symptoms include sores in the mouth and on the genitals (sex organs). More serious symptoms can include inflammation (swelling, heat, redness, and pain) in the eyes and other parts of the body. The goal of treatment is to reduce pain and prevent serious problems.

Browse full table of contents and data tables at https://www.marketresearchnest.com/behcet-disease-pipeline-review-h1-2017.html

The Behcet Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Behcet Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Unknown stages are 1, 1, 2, 3, 1 and 1 respectively.

Behcet Disease (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

 

Behcet Disease – Companies Involved in Therapeutics Development

Allergan Plc

Ixchelsis Ltd

NeuroHealing Pharmaceuticals Inc

Plethora Solutions Holdings Plc

SK Chemicals Co Ltd

 

Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=205673

 

Featured News & Press Releases
Mar 23, 2016: News Of Significant Development On The First Biotechnological Drug of Turkey from Izmir
Mar 23, 2016: Turkish signature on the biomolecules study – Hurriyet
Apr 15, 2015: Phase II Data for Apremilast in Behcet’s Disease Published in The New England Journal of Medicine
Apr 14, 2015: Delenex Announces New Clinical Data
Jun 14, 2013: Celgene Presents Results From Phase II Trial Of Oral Apremilast In Patients With Behcet’s Disease At EULAR
May 24, 2013: AbbVie And Eisai Receive Indication Approval For Treatment Of Intestinal Behcet’s Disease For Humira Pre-filled Syringe In Japan

 

Scope of this Report

- The pipeline guide provides a snapshot of the global therapeutic landscape of Behcet Disease (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Behcet Disease (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Behcet Disease (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Behcet Disease (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Behcet Disease (Cardiovascular)

 

Request Sample Copy at https://www.marketresearchnest.com/requestsample.php?reportid=205673

 

About Us:                         

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

 

Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]

+1-240-284-8070

Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.